Remove Hospital Remove Pharmacology Remove Quality of Life
article thumbnail

Patient Enrollment Commenced in Pivotal Phase 3 Trial of CardiAMP Cell Therapy for the Treatment of Ischemic Heart Failure

DAIC

BioCardia previously confirmed alignment with the United States Food and Drug Administration (FDA) on the design of the 250-patient randomized, controlled trial and the minimum of 12-month primary composite endpoint of all cause death, reduction in major adverse cardiovascular events, and improvement in quality of life.

article thumbnail

New Treatment in Pipeline for Patients with Hypertrophic Cardiomyopathy

DAIC

While invasive interventions can restore selected patients’ quality of life, pharmacologic therapies that are safe, well-tolerated and that reliably improve how patients feel and function remain an unmet need for patients with obstructive HCM. The late breaking research was presented by principal investigator Martin S.

article thumbnail

New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies

DAIC

This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life. Pharmacological and behavioral-based strategies often increase the smoking cessation rate in people with PAD, however, these strategies are underused.

article thumbnail

Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week

Cardiometabolic Health Congress

Furthermore, carrying excess weight can also have detrimental effects on mental health as individuals may experience low self-esteem, body image issues, depression, and a reduced quality of life. The Rise of Weight Loss Drugs The rise of weight loss drugs has brought with it a promising solution in the battle against obesity.

Obesity 97